Long-term follow-up of therapeutic efficacy of everolimus-eluting bioresorbable vascular scaffold in comparison to everolimus-eluting stent in treatment of chronic total occlusion guided by intracoronary imaging

Table 4 Intraprocedural and post-procedural aspect during intervention

PCI		DES group	Absorb group	Test	p value	Sig.
PCI		No. = 40	No. = 20	Test	p value	Sig.
Artery	LAD	18 (45.0%)	9 (45.0%)	0.000^a	1.000	NS
	RCA	18 (45.0%)	9 (45.0%)
	LCX	4 (10.0%)	2 (10.0%)
Antegrade or retrograde	Antegrade	30 (75.0%)	15 (75.0%)	0.000^a	1.000	NS
Antegrade or retrograde	Retrograde	10 (25.0%)	5 (25.0%)	0.000^a	1.000	NS
J score	Median (IQR)	3 (3 – 4)	3 (3–4)	− 0.679^c	0.497	NS
J score	Range	3–4	2–4	− 0.679^c	0.497	NS
Pre-dilatation	Done	40 (100.0%)	20 (100.0%)	–	–	–
Post-dilatation	Not done	2 (5.0%)	0 (0.0%)	1.034^a	0.309	NS
Post-dilatation	Done	38 (95.0%)	20 (100.0%)	1.034^a	0.309	NS
Stent length	Mean ± SD	32.53 ± 9.46	29.40 ± 8.61	1.242^b	0.219	NS
Stent length	Range	15–48	18–38	1.242^b	0.219	NS
DAPT	Given	40 (100.0%)	20 (100.0%)	–	–	–
TIMI flow intraprocedure	II	2 (5.0%)	0 (0.0%)	1.034^a	0.309	NS
TIMI flow intraprocedure	III	38 (95.0%)	20 (100.0%)	1.034^a	0.309	NS
Coronary perforation	occurred	0 (0%)	1 (0.05%)	0.000^a	1.000	NS